DZ Bank AG Reiterates Buy Rating for Merck KGaA (MRK)
Merck KGaA (FRA:MRK)‘s stock had its “buy” rating restated by DZ Bank AG in a research report issued to clients and investors on Monday.
Other analysts have also issued reports about the company. Bankhaus Lampe set a €102.00 ($112.09) target price on Merck KGaA and gave the company a “buy” rating in a research note on Tuesday, July 19th. equinet AG set a €85.00 ($93.41) price target on Merck KGaA and gave the company a “buy” rating in a report on Monday, July 18th. Deutsche Bank AG set a €110.00 ($120.88) price target on Merck KGaA and gave the company a “buy” rating in a report on Thursday, July 28th. Citigroup Inc. set a €115.00 ($126.37) price target on Merck KGaA and gave the company a “buy” rating in a report on Tuesday, July 26th. Finally, Commerzbank AG set a €101.00 ($110.99) price target on Merck KGaA and gave the company a “buy” rating in a report on Friday, July 22nd. One research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and ten have given a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of €101.19 ($111.19).
Merck KGaA (FRA:MRK) traded down 0.08% during mid-day trading on Monday, reaching €97.20. The company’s stock had a trading volume of 2,314 shares. The company has a market cap of €42.26 billion and a price-to-earnings ratio of 30.41. Merck KGaA has a 12 month low of €70.87 and a 12 month high of €100.00. The stock’s 50 day moving average is €95.75 and its 200 day moving average is €89.96.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/17/dz-bank-ag-reiterates-buy-rating-for-merck-kgaa-mrk.html
About Merck KGaA
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.